-
Concanamycin A: V-type H+-ATPase Inhibitor for Cancer Resear
2026-05-14
Concanamycin A empowers researchers to dissect V-ATPase-mediated signaling, apoptosis, and invasion in tumor models with nanomolar precision. This guide translates the latest metabolic adaptation findings and hands-on workflow optimizations into actionable cancer biology protocols.
-
EPZ5676: Advanced DOT1L Inhibitor Workflows for Leukemia Res
2026-05-14
EPZ5676, a nanomolar-potency DOT1L inhibitor from APExBIO, transforms epigenetic and leukemia research with unmatched selectivity and robust workflow integration. This article delivers actionable protocols, troubleshooting strategies, and experimental innovations to maximize assay success and data fidelity.
-
Optimizing Apoptosis Assays with Z-VAD-FMK (SKU A1902): Prac
2026-05-13
This article addresses real-world laboratory challenges in apoptosis research, offering evidence-based solutions with Z-VAD-FMK (Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone), SKU A1902. It guides researchers on protocol design, data interpretation, and vendor reliability, highlighting how APExBIO’s compound streamlines cell viability workflows and improves reproducibility.
-
Z-VEID-FMK: Precision Caspase-6 Inhibitor for Apoptosis Rese
2026-05-13
Z-VEID-FMK is a selective caspase-6 inhibitor enabling high-specificity dissection of apoptotic pathways in neuronal and immune cell models. Its irreversible binding and robust performance streamline apoptosis assays and support advanced virology and neurodegeneration research.
-
KPT-330 (Selinexor): Transforming Nuclear Export in Oncology
2026-05-12
This article offers translational researchers a mechanistic and strategic deep dive into KPT-330 (Selinexor), the oral and selective CRM1 inhibitor, as a disruptive force in cancer research. By bridging emerging evidence from key preclinical studies with actionable workflow guidance, it empowers oncology innovators to drive reproducibility and advance beyond conventional paradigms—specifically in apoptosis induction, cell cycle arrest, and overcoming chemoresistance in challenging tumor models such as triple-negative breast cancer.
-
Applied Mammalian Cell Analysis with Live-Dead Cell Staining
2026-05-12
Unlock accurate, rapid discrimination of live and dead mammalian cells using the Live-Dead Cell Staining Kit I (Calcein AM/PI) from APExBIO. This guide bridges workflow enhancements, troubleshooting, and practical assay translation—empowering researchers to excel in advanced mammalian cell viability and cytotoxicity studies.
-
miR-18a/ALOXE3 Axis Modulates Ferroptosis and Migration in G
2026-05-11
This study reveals that miR-18a promotes glioblastoma by directly suppressing ALOXE3 expression, thereby impairing ALOXE3-mediated ferroptosis and enhancing tumor cell migration. The findings underscore a new regulatory axis with therapeutic potential in targeting GBM lipid metabolism and cell death pathways.
-
RNAi Screen Reveals Vesicular Transport Factors in SARS-CoV-
2026-05-11
Kerr et al. present a comprehensive RNA interference screen identifying host vesicular transport proteins as key facilitators of SARS-CoV-2 assembly and release. Their findings highlight Rab11a-mediated trafficking and CDK9 inhibition as promising targets for host-directed antiviral research, expanding the landscape of therapeutic strategies beyond viral components.
-
Latrunculin B Inhibitor: Precision Tool for Actin Dynamics R
2026-05-10
Latrunculin B empowers researchers to achieve rapid, reversible actin cytoskeleton disruption with high temporal control, making it a gold standard for short-term cellular actin dynamics research. Its transient, tunable inhibition profile unlocks advanced protocol optimization and robust troubleshooting in cytoskeletal organization studies.
-
CHIR 99021 trihydrochloride: Reliable GSK-3 Inhibition for S
2026-05-09
This article explores how CHIR 99021 trihydrochloride (SKU B5779) from APExBIO addresses key challenges in cell viability, proliferation, and organoid differentiation assays. By grounding recommendations in peer-reviewed data and real-world scenarios, we demonstrate how this potent and selective GSK-3 inhibitor enhances workflow reproducibility and biological relevance in insulin signaling, stem cell maintenance, and high-throughput screening.
-
Saracatinib (AZD0530): Empowering Cancer and Neurobiology As
2026-05-08
Saracatinib (AZD0530) delivers nanomolar potency for targeted inhibition of Src and Abl kinases, enabling precise dissection of cancer cell signaling and synaptic pathways. Discover data-driven protocols, advanced experimental workflows, and troubleshooting strategies to maximize reproducibility in cancer biology and translational neuroscience using APExBIO’s trusted reagent.
-
MLN4924 (SKU B1036): Enhancing Reproducibility in Neddylatio
2026-05-08
This article addresses common challenges in cell viability and cytotoxicity assays by exploring scenario-driven applications of MLN4924 (SKU B1036), a potent NEDD8-activating enzyme inhibitor. Through evidence-based Q&As, we illustrate how APExBIO’s MLN4924 supports reproducible cancer biology research and enables rigorous neddylation pathway interrogation.
-
CTDNEP1-NEP1R1 Complex: Distinct Roles in ER Lipid Regulatio
2026-05-07
This study uncovers how the regulatory subunit NEP1R1 differentially stabilizes CTD nuclear envelope phosphatase 1 (CTDNEP1) in endoplasmic reticulum (ER) membrane synthesis versus lipid droplet storage. These findings refine our understanding of ER lipid homeostasis and have implications for mechanisms involving protein and lipid quality control.
-
Wnt Agonist 1 (BML-284): Precision Tools for Wnt Pathway Res
2026-05-07
Wnt agonist 1 (BML-284) empowers researchers to simulate and dissect canonical Wnt signaling in cell differentiation, chemoresistance, and developmental biology. This guide translates key findings and protocols into actionable workflows for reproducible, high-sensitivity Wnt pathway activation.
-
CHIR-99021 (CT99021): Precision GSK-3 Inhibition in Stem Cel
2026-05-06
CHIR-99021 (CT99021) delivers unmatched selectivity for GSK-3α/β, empowering high-fidelity control of Wnt/β-catenin and TGF-β/Nodal pathways in stem cell and disease modeling assays. This guide decodes practical workflows, troubleshooting, and translational innovations using APExBIO’s trusted reagent.